The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Benoit J ArsenaultS Matthijs Boekholdt

Abstract

Screening for increased waist circumference and hypertriglyceridemia (the hypertriglyceridemic-waist phenotype) has been proposed as an inexpensive approach to identify patients with excess intra-abdominal adiposity and associated metabolic abnormalities. We examined the relationship between the hypertriglyceridemic-waist phenotype to the risk of coronary artery disease in apparently healthy individuals. A total of 21,787 participants aged 45-79 years were followed for a mean of 9.8 (standard deviation 1.7) years. Coronary artery disease developed in 2109 of them during follow-up. The hypertriglyceridemic-waist phenotype was defined as a waist circumference of 90 cm or more and a triglyceride level of 2.0 mmol/L or more in men, and a waist circumference of 85 cm or more and a triglyceride level of 1.5 mmol/L or more in women. Compared with participants who had a waist circumference and triglyceride level below the threshold, those with the hypertriglyceridemic-waist phenotype had higher blood pressure indices, higher levels of apolipoprotein B and C-reactive protein, lower levels of high-density lipoprotein cholesterol and apolipoprotein A-I, and smaller low-density lipoprotein particles. Among men, those with the hypertriglyce...Continue Reading

Associated Clinical Trials

References

Jun 27, 1998·JAMA : the Journal of the American Medical Association·B LamarcheJ P Després
Dec 4, 2003·Atherosclerosis·Michael J LaMonteJ Larry Durstine
Feb 11, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M SolatiF Azizi
Jul 21, 2004·Hypertension·Anna Maria SironiEle Ferrannini
Oct 19, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S CzernichowJ-M Oppert
Dec 15, 2006·Nature·Jean-Pierre Després, Isabelle Lemieux
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Børge G NordestgaardAnne Tybjaerg-Hansen
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Sandeep BansalPaul M Ridker
Jul 25, 2007·Archives of Internal Medicine·Benoit J ArsenaultJean-Pierre Després
Dec 6, 2007·The Canadian Journal of Cardiology·Isabelle LemieuxJean-Pierre Després
Nov 14, 2008·The New England Journal of Medicine·T PischonE Riboli

❮ Previous
Next ❯

Citations

Aug 29, 2013·Current Atherosclerosis Reports·Kalypso Karastergiou, Susan K Fried
Jan 10, 2012·Metabolic Syndrome and Related Disorders·Sophia S K YuAnne E Sumner
Dec 25, 2012·Metabolic Syndrome and Related Disorders·Zhaoping LiDavid Heber
Dec 12, 2012·Metabolic Syndrome and Related Disorders·Sophia S K YuAnne E Sumner
May 11, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Grace M EgelandT Kue Young
Sep 21, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·T DuX Yu
Jun 14, 2013·Journal of Obesity·Scott M GrundyGloria Lena Vega
Apr 4, 2014·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Daniel O ClarkHugh C Hendrie
Oct 20, 2014·Reviews in Endocrine & Metabolic Disorders·Patrick MathieuJean-Pierre Després
Jan 26, 2011·Nature Reviews. Cardiology·Beatriz Cepeda-ValeryAbel Romero-Corral
Dec 30, 2014·Postgraduate Medicine·Jacinthe LeclercPaul Poirier
May 23, 2014·Expert Review of Cardiovascular Therapy·Altan OnatAyşem Kaya
Feb 11, 2016·BMC Complementary and Alternative Medicine·Bum Ju LeeJong Yeol Kim
Feb 13, 2014·Journal of Immigrant and Minority Health·Mary Vanellys Díaz-SantanaCynthia M Pérez Cardona
Jul 8, 2011·Metabolism: Clinical and Experimental·Patricia BlackburnJean-Pierre Després
Sep 30, 2015·Diabetes/metabolism Research and Reviews·Yongcheng RenDongsheng Hu
Oct 18, 2015·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·J PoirierG M Egeland
Sep 12, 2013·European Journal of Clinical Investigation·Altan OnatHüsniye Yüksel
Feb 13, 2015·IEEE Journal of Biomedical and Health Informatics·Bum Ju Lee, Jong Yeol Kim
Jun 15, 2012·Atherosclerosis·Patricia BlackburnJean-Pierre Després
Aug 22, 2015·BioMed Research International·Ya-Fang LiuChi-Ming Chu
Jun 1, 2015·Diabetes Research and Clinical Practice·Farhad HosseinpanahFereidoun Azizi
Mar 5, 2013·International Journal of Cardiology·Xianglan ZhangWei Zheng
Apr 3, 2013·Jornal de pediatria·Maria Ester P da Conceição-MachadoAna Marlúcia O Assis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.